Challenges in diagnosis and treatment of fasciola hepatica infection
dc.contributor.authorid | 0000-0003-1935-9235 | |
dc.contributor.authorid | 0000-0003-3823-4454 | |
dc.contributor.authorid | 0000-0002-1840-0040 | |
dc.contributor.authorid | 0000-0002-1178-7449 | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Ergönül, Mehmet Önder | |
dc.contributor.kuauthor | Keske, Şiran | |
dc.contributor.kuauthor | Pınarlık, Fatihan | |
dc.contributor.kuauthor | Rozanes, İzzet | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | PhD Student | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.researchcenter | Koç Üniversitesi İş Bankası Enfeksiyon Hastalıkları Uygulama ve Araştırma Merkezi (EHAM) / Koç University İşbank Center for Infectious Diseases (KU-IS CID) | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | Graduate School of Health Sciences | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | 110398 | |
dc.contributor.yokid | 125555 | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | 125890 | |
dc.date.accessioned | 2025-01-19T10:33:56Z | |
dc.date.issued | 2023 | |
dc.description.abstract | A 57-year-old female patient presented with fever, nausea, vomiting, loss of appetite, and weight loss within the last two months. Ceftriaxone and metronidazole therapy was start-ed upon discovery of a liver abscess but provided no benefit. Following the of abscess bi-opsy, the patient developed fever, itching, anemia, acute renal failure, hyperbilirubinemia, and eosinophilia that required intensive care unit (ICU) admission. The Fasciola hepatica antibodies were detected by enzyme-linked immunosorbent assay (ELISA). Triclabendazole was started, after which the symptoms and magnetic resonance imaging (MRI) findings regressed. Even without eosinophilia, F. hepatica should be considered in cases with a liver abscess that does not respond to antibiotics. | |
dc.description.indexedby | WoS | |
dc.description.indexedby | PubMed | |
dc.description.indexedby | TR Dizin | |
dc.description.issue | 1 | |
dc.description.openaccess | hybrid | |
dc.description.publisherscope | International | |
dc.description.volume | 5 | |
dc.identifier.doi | 10.36519/idcm.2023.197 | |
dc.identifier.issn | 2667-646X | |
dc.identifier.quartile | Q4 | |
dc.identifier.uri | https://doi.org/10.36519/idcm.2023.197 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/26682 | |
dc.identifier.wos | 1085178000007 | |
dc.keywords | Fascioliasis | |
dc.keywords | Fasciola hepatica | |
dc.keywords | Liver abscess | |
dc.keywords | Triclabendazole | |
dc.language | en | |
dc.publisher | DOC Design Informatics Co Ltd | |
dc.source | Infectious Diseases and Clinical Microbiology | |
dc.subject | Medicine | |
dc.title | Challenges in diagnosis and treatment of fasciola hepatica infection | |
dc.type | Journal Article |